Differential attenuation by atropine and d-amphetamine on hyperactivity: possible clinical implications
Psychopharmacology
; 54: 25-30, 1977.
Article
em En
| MedCarib
| ID: med-12149
Biblioteca responsável:
JM3.1
Localização: JM3.1; Reprint Collection
ABSTRACT
Intraperitoneal administration of physostigmine (0.025 to 0.18 mg/kg) to rats resulted in dignificant increases in motor activity as measured with jiggle platforms. Doses of physostigmine 0.2 mg/kg or more decreased motor activity. The physostigmine-induced hyperactivity was attenuated by atropine (5 mg/kg) given before or after physostigmine (0.05 mg/kg). On the contrary, d-amphetamine (2 mg/kg), given before or after, significantly potentiated the physostigmine-induced increase in motor activity. The relevance of the cholinergic system in mediating hyperactive behaviour in children is discussed. (AU)
Buscar no Google
Coleções:
01-internacional
Base de dados:
MedCarib
Assunto principal:
Atropina
/
Dextroanfetamina
/
Atividade Motora
Limite:
Animals
Idioma:
En
Revista:
Psychopharmacology
Ano de publicação:
1977
Tipo de documento:
Article